Heart and Vascular
KINSHIP-DCM
Heart Failure
A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy
Contact Research Team:
[email protected]
Site principal investigator:
Andrew Kao, MD
Learn more about this study:
NCT07210723